COMMD9-CYP19A1 Fusion FISH Probe
The COMMD9-CYP19A1 Fusion FISH Probe is used to confirm a fusion of the COMMD9 and CYP19A1 genes. The fusion of the COMMD9 and CYP19A1 genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
COMMD9-CYP19A1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-RERE | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-REOR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-REGO | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-REGR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-REAQ | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-ORRE | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-OROR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-ORGO | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-ORAQ | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GORE | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GOOR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GOGO | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GOGR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GOAQ | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GRRE | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GROR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GRGO | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GRGR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-GRAQ | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-AQRE | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-AQOR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-AQGO | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-AQGR | 20 (40 μL) | 200 μL | ||
COMMD9-CYP19A1-20-AQAQ | 20 (40 μL) | 200 μL |
CYP19A1 Gene Summary
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
Gene Name: Cytochrome P450 Family 19 Subfamily A Member 1
Chromosome: CHR15: 51500253 -51630795
Locus: 15q21.2
COMMD9 Gene Summary
The COMM Domain Containing 9 (COMMD9) gene is located on chr11 :36293841-36310999 at 11p13.
Gene Name: COMM Domain Containing 9
Chromosome: CHR11: 36293841 -36310999
Locus: 11p13
Gene Diseases
The COMMD9 CYP19A1 Fusion has been associated with the following diseases:
Disease Name |
---|
Liver Hepatocellular Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|